Breaking News: Cue Biopharma Sets Record with $12.0 Million Public Offering
Cue Biopharma Announces Public Offering of Common Stock September 26, 2024 Boston, MA Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company specializing in therapeutic biologics, has announced the pricing of an underwritten public offering of common stock. The offering includes 11,564,401 shares of common stock and accompanying common stock warrants, as well as pre-funded…